Not finding it? Sign in to also search OpenAlex live.
-
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Robert Landewé, Désirée M F M van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, +6 more
73citations -
Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity2021 Cochrane Database of Systematic Reviews article Medicine Spondyloarthritis Studies and Treatments Open access
Jodie Avery, Samuel Whittle, Renea V Johnston, Liesl Grobler, Bayden J McKenzie, Sheila Cyril, +2 more
0citations -
Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study2025 Journal of Thrombosis and Haemostasis article Medicine Hemophilia Treatment and Research Open access
Konrad van der Zwet, Marjon H. Cnossen, Floor C. J. I. Heubel-Moenen, Saskia E.M. Schols, Paula F. Ypma, Paul L. den Exter, +41 more
8citations -
Reduction of organ of interest dose in proton therapy for oesophageal cancer through optimized setup robustness settings and online adaptation2026 Physics and Imaging in Radiation Oncology article Physics and Astronomy Advanced Radiotherapy Techniques Open access
Eva van Weerd, Anne Lisa Wolf, Steven Habraken, Yvonne L.B. Klaver, Mischa S. Hoogeman
0citations -
Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial
Celia A J Michielsens, Nadine Boers, Nathan den Broeder, Mark H. Wenink, Aatke van der Maas, Elien A. M. Mahler, +5 more
21citations -
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Celia A J Michielsens, Nathan den Broeder, Frank H J van den Hoogen, Elien A. M. Mahler, Steven Teerenstra, Désirée M F M van der Heijde, +2 more
35citations -
Dose reduction of biologics in psoriasis:The role of the GIDS program in implementation within Dutch University Medical Centers2026 Research Publications (Maastricht University) article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis
Liana Barenbrug, Elise Avenarius, I M Scholl, Phyllis Ira Spuls, Martijn van Doorn, Ly Nguyen, +6 more
0citations -
Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendations2024 Regulatory Toxicology and Pharmacology article Veterinary Animal testing and alternatives Open access
Manon E. W. Beekhuijzen, Jason C. Manton, Pragati Sawhney Coder, Katy O. Goyak, Rashin Ghaffari, Susan L. Makris, +3 more
9citations -
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study2022 Journal of Gastrointestinal and Liver Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Rachel Louise West, Maurice G. Rüssel, Alexander G L Bodelier, Johan P. Kuijvenhoven, Karlien F. Bruin, Jeroen M. Jansen, +12 more
11citations -
Prediction of dose reductions and impact of reduced starting doses of CDK4 /6i on effectiveness in HR ‐positive/ HER2 ‐negative metastatic breast cancer: Real‐world data from the OPAL registry
Patrick Marschner, Marc Thill, Mark‐Oliver Zahn, Anja Welt, Arnd Nusch, Gabriele Kaltenecker, +13 more
3citations -
P0810DOSAGE REDUCTION OF LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL DYSFUNCTION: EFFECTS ON ANTI-XA LEVELS AND CLINICAL OUTCOMES2020 Nephrology Dialysis Transplantation article Medicine Venous Thromboembolism Diagnosis and Management Open access
Paul Hornung, Meriem Khairoun, Friedo Wilhelm Dekker, Karin A. H. Kaasjager, Albert Huisman, Lily Jakulj, +4 more
0citations -
Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study2020 Blood Advances article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Vikas K Gupta, Denise Wolleschak, Hans Carl Hasselbalch, Alessandro Maria Vannucchi, Steffen Koschmieder, Francisco Cervantes, +5 more
11citations